Forbes William P: insider trades.
Forbes William P reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Forbes William P
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Heron Therapeutics, Inc. /De/ (HRTX) | Officer · EVP, Chief Development Officer | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-31 | Heron Therapeutics, Inc. /De/ | M | 11,694 | — | 244,499 | Form 4 |
| 2026-07-31 | Heron Therapeutics, Inc. /De/ | F | 3,326 | $0.5 | 241,173 | Form 4 |
| 2026-07-30 | Heron Therapeutics, Inc. /De/ | F | 3,348 | $0.5 | 232,805 | Form 4 |
| 2026-07-30 | Heron Therapeutics, Inc. /De/ | M | 11,769 | — | 236,153 | Form 4 |
| 2026-07-19 | Heron Therapeutics, Inc. /De/ | F | 1,101 | $0.47 | 224,384 | Form 4 |
| 2026-07-19 | Heron Therapeutics, Inc. /De/ | M | 3,874 | — | 225,485 | Form 4 |
Questions
What stock did Forbes William P buy or sell?
Forbes William P reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
Is Forbes William P the same person as other filers with this name?
This page covers SEC CIK 1314760 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/forbes-william-p-1314760.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.